Back to Search
BRIAN LINDEMAN, M.D.
M.D.
Family Medicine Physician
NPI: 1003081241IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF TOLEDO COLLEGE OF MEDICINE
Class of 2005
Research & Publications (9)
[Factors contributing to interindividual variability to chemical toxicity].
PMID 11998714·Tidsskr Nor Laegeforen·2002
6-review
The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver.
PMID 10708481·Mol Carcinog·2000
4-observational
Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
PMID 19231415·Ann Thorac Surg·2009
8-other
Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes.
PMID 18026139·Oncogene·2008
7-preclinical
Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
PMID 17711579·Mol Cancer·2007
8-other
CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
PMID 17635516·Cell Prolif·2007
7-preclinical
Impaired nuclear accumulation and shortened phosphorylation of ERK after growth factor stimulation in cultured hepatocytes from rats exposed to 2-acetylaminofluorene.
PMID 10900465·Mol Carcinog·2000
7-preclinical
Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells.
PMID 10653583·J Histochem Cytochem·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5005 NE SANDY BLVD
PORTLAND, OR 97213 - Phone
- (503) 233-6940
Quick Facts
- NPI
- 1003081241
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 9
Are you this provider?
Claim Your Profile